1. Home
  2. GLPG vs AMPL Comparison

GLPG vs AMPL Comparison

Compare GLPG & AMPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Galapagos NV

GLPG

Galapagos NV

HOLD

Current Price

$31.07

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo Amplitude Inc.

AMPL

Amplitude Inc.

HOLD

Current Price

$10.98

Market Cap

1.7B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLPG
AMPL
Founded
1999
2012
Country
Belgium
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.7B
IPO Year
2005
2021

Fundamental Metrics

Financial Performance
Metric
GLPG
AMPL
Price
$31.07
$10.98
Analyst Decision
Hold
Strong Buy
Analyst Count
4
11
Target Price
$31.33
$14.82
AVG Volume (30 Days)
89.8K
1.0M
Earning Date
11-05-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$336,643,201.00
$329,919,000.00
Revenue This Year
$3.61
$16.63
Revenue Next Year
N/A
$14.17
P/E Ratio
N/A
N/A
Revenue Growth
10.31
12.78
52 Week Low
$22.36
$7.55
52 Week High
$37.78
$14.88

Technical Indicators

Market Signals
Indicator
GLPG
AMPL
Relative Strength Index (RSI) 44.79 55.45
Support Level $31.41 $11.03
Resistance Level $32.75 $11.71
Average True Range (ATR) 0.54 0.37
MACD 0.03 0.03
Stochastic Oscillator 17.53 57.02

Price Performance

Historical Comparison
GLPG
AMPL

About GLPG Galapagos NV

Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology. The group focuses on unmet medical needs, it synergizes compelling science, technology, and collaborative approaches to create a deep pipeline of medicines. Its clinical pipeline includes: GLPG5101, a CD19 CAR-T product candidate decentralized manufactured, currently in Phase 1/2 in rrNHL; GLPG5301, a BCMA CAR-T product candidate decentralized manufactured, currently in Phase 1 in rrMM; and GLPG3667, a TYK2 inhibitor currently in Phase 2 clinical trial in DM and SLE. It derives maximum revenue from the United States of America.

About AMPL Amplitude Inc.

Amplitude Inc is a Software company that provides a Digital Analytics Platform that helps companies analyze their customer behavior within digital products. The Company delivers its application over the Internet as a subscription service using a software-as-a-service (SaaS) model and also it offers customer support related to initial implementation setup, ongoing support services, and application training. The company generates revenue primarily through selling subscriptions to the platform. The company derives a majority of its revenue from the United States.

Share on Social Networks: